We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 11,714

Insurer Merger Saga Ends Without Guidance on Efficiency Claims
  • Manatt Phelps & Phillips LLP
  • USA
  • May 24 2017

Prior to calling off its nearly two-year fight to acquire competing insurer Cigna last week, Anthem urged the Supreme Court of the United States to


Commercial Division Partially Vacates ICC Arbitration Award in Artificial Sweetener Dispute
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • May 24 2017

Justice Charles Ramos of the New York Commercial Division partially vacated an International Chamber of Commerce (“ICC”) arbitration award in a major


Eyes Across the Atlantic: Coordination and Management of Global Private Antitrust Litigation
  • Sheppard Mullin Richter & Hampton LLP
  • European Union, United Kingdom, USA
  • May 23 2017

In years past, the focus of private international antitrust disputes was the United States. Over a century of experience, treble damages, class


How drug prices are hiked and what is being done to tackle the problem
  • Charles Russell Speechlys LLP
  • United Kingdom, USA
  • May 22 2017

There has been negative publicity in the national press about drug manufacturers increasing the price of some medicines significantly: so called


Carbon and Alloy Steel: Commission Hearing on Dismissal of Antitrust Claims
  • Morrison & Foerster LLP
  • USA
  • May 19 2017

On April 20, 2017, the Commission heard oral arguments in Certain Carbon and Alloy Steel Products, Inv. No. 337TA-1002, in connection with its review


Global Inquiries into Drug Price Increases
  • Patterson Belknap Webb & Tyler LLP
  • European Union, USA
  • May 19 2017

European competition authorities announced this week an investigation into Aspen Pharmacare’s recent price hikes of five cancer drugs. The European


100 Million Reasons For Open Source Compliance
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • May 19 2017

CoKinetic Systems Corporation filed suit against Panasonic Avionics Corporation, seeking damages in excess of $100 million, in part, for violation of


Hope for a cleaner Brexit after ECJ ruling
  • Bryan Cave LLP
  • European Union, United Kingdom, USA
  • May 18 2017

In a ruling which is likely to have positive implications for a possible Brexit deal, the European Court of Justice (ECJ) on the 16 May 2017 opened


Avoiding Fines and Disgorgement of Profits under PRC Anti-Bribery Provisions
  • O'Melveny & Myers LLP
  • USA
  • May 17 2017

Performance based compensation incentives are a common way to encourage sales for many businesses around the world


Circuit Court Rejects Claims that Medical-Surgical Distributors’ Discounts Violated the Sherman Act
  • Hausfeld LLP
  • USA
  • May 17 2017

Cases in which vertical restraints are challenged under Section 1 of the Sherman Act often require proof that the defendant has